Fundraising Fox

Lucid Diagnostics

NASDAQ: LUCD

Lake Forest, US · Delaware corporation · 1 known investors

luciddx.com

Lucid Diagnostics develops tests for the early detection of esophageal precancer using targeted next-generation sequencing, aimed at helping clinicians detect and treat the condition before it progresses to cancer. The company operates a CLIA-certified, CAP-accredited clinical lab licensed by the New York State Department of Health.

BiotechDigital HealthHealthtechMedical Devicesin /luciddiagnostics@LucidDiag

Founders & leadership

MA
Michael A GordonExecutive Officer
SO
Shaun O'NeilExecutive Officer
LA
Lishan AklogChairman & CEO
DM
Dennis McGrathExecutive Officer
DW
Debra WhiteDirector
SL
Stanley LapidusDirector
BD
Brian deGuzmanChief Technology Officer & Chief Compliance Officer
DA
DENNIS A. MATHEISDirector
RM
Ronald M SparksDirector
DJ
DEBRA J. WHITEDirector
SN
STANLEY N. LAPIDUSDirector
JL
James L CoxDirector

Investors · 1

Reported raises · per SEC filings

Form D private placements
$21.9MraisedDec 2024 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • MICHAEL A. GORDONExecutive Officer
  • DENNIS A. MATHEISDirector
  • SHAUN O'NEILExecutive Officer
  • RONALD M. SPARKSDirector
  • LISHAN AKLOGExecutive Officer, Director
  • DEBRA J. WHITEDirector
  • STANLEY N. LAPIDUSDirector
  • DENNIS M. MCGRATHExecutive Officer
  • JAMES L. COXDirector
  • JACQUE J. SOKOLOVDirector
Offering amount
$21.9M
Amount sold
$21.9M
First sale
Nov 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$5MraisedNov 2023 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stanley LapidusDirector
  • Michael A GordonExecutive Officer
  • Jacque J SokolovDirector
  • Dennis McGrathExecutive Officer
  • Shaun O'NeilExecutive Officer
  • James L CoxDirector
  • Ronald M SparksDirector
  • Debra WhiteDirector
  • Lishan AklogExecutive Officer, Director
Offering amount
$5M
Amount sold
$5M
Minimum investment
$250K
First sale
Oct 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$11.1MraisedApr 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Debra WhiteDirector
  • James L CoxDirector
  • Shaun O'NeilExecutive Officer
  • Michael A GordonExecutive Officer
  • Ronald M SparksDirector
  • Dennis McGrathExecutive Officer
  • Jacque J SokolovDirector
  • Lishan AklogExecutive Officer, Director
  • Stanley LapidusDirector
Offering amount
$11.1M
Amount sold
$11.1M
First sale
Mar 2023
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$13.6MraisedMar 2023 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Shaun O'NeilExecutive Officer
  • Ronald M SparksDirector
  • Debra WhiteDirector
  • Dennis McGrathExecutive Officer
  • Lishan AklogExecutive Officer, Director
  • Jacque J SokolovDirector
  • Stanley LapidusDirector
  • Michael A GordonExecutive Officer
  • James L CoxDirector
Offering amount
$20M
Amount sold
$13.6M
Minimum investment
$250K
First sale
Mar 2023
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.